IRCT20200105046010N67招募中未知
In- Vivo Bioequivalence study of Ibuprofen tablet 800 mg Mofid Pharma (DRASTIFEN® ER. 800 mgTab, Mofid Pharma, Iran) with brand drugs (BRUFEN® ER. 800 mg Tab, Mylan, Germany) in Iranian healthy volunteers.
Teb Mofid Nikan Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-55 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
已完成
Unknown
Bioequivalence study of Ibuprofen ER 800 mgIRCT20220111053692N13Kimiara Heram Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of Ibuprofen 800 mg tabletIRCT20200623047902N29Darou Darman Arang company24
招募中
2 期
Comparative Assessment of the Effect of Ibuprofen and ketorolac on Edema Trismus and Pain after lower Third Molar SurgeryIRCT20191014045101N1Yazd University of Medical Sciences20
招募中
2 期
Comparative evaluation of the effect of ibuprofen lysine & gelofen - acetaminophen on paiIrreversible pulpitis.K04.0PulpitisIRCT20140527017880N8Kermanshah University of Medical Sciences60
招募中
2 期
Comparison of the effect of intravenous ibuprofen, intravenous acetaminophen, and intravenous morphine sulfate on treatment of abdominal pain in patients with appendicitisAppendicitis.Acute appendicitisIRCT201709279014N190Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences105